Central nervous system PET-CT imaging reveals regional impairments in pediatric patients with Wolfram syndrome.

Wolfram syndrome (WFS) is inherited as an autosomal recessive disease with main clinical features of diabetes mellitus, optic atrophy, diabetes insipidus and deafness. However, various neurological defects may also be detected. The aim of this study was to evaluate aspects of brain structure and fun...

Full description

Bibliographic Details
Main Authors: Agnieszka Zmyslowska, Bogdan Malkowski, Wojciech Fendler, Maciej Borowiec, Karolina Antosik, Piotr Gnys, Dobromila Baranska, Wojciech Mlynarski
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4277290?pdf=render
id doaj-cf764e5ccd884d48ac5aeb8174880856
record_format Article
spelling doaj-cf764e5ccd884d48ac5aeb81748808562020-11-25T01:45:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01912e11560510.1371/journal.pone.0115605Central nervous system PET-CT imaging reveals regional impairments in pediatric patients with Wolfram syndrome.Agnieszka ZmyslowskaBogdan MalkowskiWojciech FendlerMaciej BorowiecKarolina AntosikPiotr GnysDobromila BaranskaWojciech MlynarskiWolfram syndrome (WFS) is inherited as an autosomal recessive disease with main clinical features of diabetes mellitus, optic atrophy, diabetes insipidus and deafness. However, various neurological defects may also be detected. The aim of this study was to evaluate aspects of brain structure and function using PET-CT (positron emission tomography and computed tomography) and MRI (magnetic resonance imaging) in pediatric patients with WFS. Regional changes in brain glucose metabolism were measured using standardized uptake values (SUVs) based on images of (18F) fluorodeoxyglucose (FDG) uptake in 7 WFS patients aged 10.1-16.0 years (mean 12.9±2.4) and in 20 healthy children aged 3-17.9 years (mean 12.8±4.1). In all patients the diagnosis of WFS was confirmed by DNA sequencing of the WFS1 gene. Hierarchical clustering showed remarkable similarities of glucose uptake patterns among WFS patients and their differences from the control group. SUV data were subsequently standardized for age groups <13 years old and>13 years old to account for developmental differences. Reduced SUVs in WFS patients as compared to the control group for the bilateral brain regions such as occipital lobe (-1.24±1.20 vs. -0.13±1.05; p = 0.028) and cerebellum (-1.11±0.69 vs. -0.204±1.00; p = 0.036) were observed and the same tendency for cingulate (-1.13±1.05 vs. -0.15±1.12; p = 0.056), temporal lobe (-1.10±0.98 vs. -0.15±1.10; p = 0.057), parietal lobe (-1.06±1.20 vs. -0.08±1.08; p = 0.058), central region (-1.01±1.04 vs. -0.09±1.06; p = 0.060), basal ganglia (-1.05±0.74 vs. -0.20±1.07; p = 0.066) and mesial temporal lobe (-1.06±0.82 vs. -0.26±1.08; p = 0.087) was also noticed. After adjusting for multiple hypothesis testing, the differences in glucose uptake were non-significant. For the first time, regional differences in brain glucose metabolism among patients with WFS were shown using PET-CT imaging.http://europepmc.org/articles/PMC4277290?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Agnieszka Zmyslowska
Bogdan Malkowski
Wojciech Fendler
Maciej Borowiec
Karolina Antosik
Piotr Gnys
Dobromila Baranska
Wojciech Mlynarski
spellingShingle Agnieszka Zmyslowska
Bogdan Malkowski
Wojciech Fendler
Maciej Borowiec
Karolina Antosik
Piotr Gnys
Dobromila Baranska
Wojciech Mlynarski
Central nervous system PET-CT imaging reveals regional impairments in pediatric patients with Wolfram syndrome.
PLoS ONE
author_facet Agnieszka Zmyslowska
Bogdan Malkowski
Wojciech Fendler
Maciej Borowiec
Karolina Antosik
Piotr Gnys
Dobromila Baranska
Wojciech Mlynarski
author_sort Agnieszka Zmyslowska
title Central nervous system PET-CT imaging reveals regional impairments in pediatric patients with Wolfram syndrome.
title_short Central nervous system PET-CT imaging reveals regional impairments in pediatric patients with Wolfram syndrome.
title_full Central nervous system PET-CT imaging reveals regional impairments in pediatric patients with Wolfram syndrome.
title_fullStr Central nervous system PET-CT imaging reveals regional impairments in pediatric patients with Wolfram syndrome.
title_full_unstemmed Central nervous system PET-CT imaging reveals regional impairments in pediatric patients with Wolfram syndrome.
title_sort central nervous system pet-ct imaging reveals regional impairments in pediatric patients with wolfram syndrome.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Wolfram syndrome (WFS) is inherited as an autosomal recessive disease with main clinical features of diabetes mellitus, optic atrophy, diabetes insipidus and deafness. However, various neurological defects may also be detected. The aim of this study was to evaluate aspects of brain structure and function using PET-CT (positron emission tomography and computed tomography) and MRI (magnetic resonance imaging) in pediatric patients with WFS. Regional changes in brain glucose metabolism were measured using standardized uptake values (SUVs) based on images of (18F) fluorodeoxyglucose (FDG) uptake in 7 WFS patients aged 10.1-16.0 years (mean 12.9±2.4) and in 20 healthy children aged 3-17.9 years (mean 12.8±4.1). In all patients the diagnosis of WFS was confirmed by DNA sequencing of the WFS1 gene. Hierarchical clustering showed remarkable similarities of glucose uptake patterns among WFS patients and their differences from the control group. SUV data were subsequently standardized for age groups <13 years old and>13 years old to account for developmental differences. Reduced SUVs in WFS patients as compared to the control group for the bilateral brain regions such as occipital lobe (-1.24±1.20 vs. -0.13±1.05; p = 0.028) and cerebellum (-1.11±0.69 vs. -0.204±1.00; p = 0.036) were observed and the same tendency for cingulate (-1.13±1.05 vs. -0.15±1.12; p = 0.056), temporal lobe (-1.10±0.98 vs. -0.15±1.10; p = 0.057), parietal lobe (-1.06±1.20 vs. -0.08±1.08; p = 0.058), central region (-1.01±1.04 vs. -0.09±1.06; p = 0.060), basal ganglia (-1.05±0.74 vs. -0.20±1.07; p = 0.066) and mesial temporal lobe (-1.06±0.82 vs. -0.26±1.08; p = 0.087) was also noticed. After adjusting for multiple hypothesis testing, the differences in glucose uptake were non-significant. For the first time, regional differences in brain glucose metabolism among patients with WFS were shown using PET-CT imaging.
url http://europepmc.org/articles/PMC4277290?pdf=render
work_keys_str_mv AT agnieszkazmyslowska centralnervoussystempetctimagingrevealsregionalimpairmentsinpediatricpatientswithwolframsyndrome
AT bogdanmalkowski centralnervoussystempetctimagingrevealsregionalimpairmentsinpediatricpatientswithwolframsyndrome
AT wojciechfendler centralnervoussystempetctimagingrevealsregionalimpairmentsinpediatricpatientswithwolframsyndrome
AT maciejborowiec centralnervoussystempetctimagingrevealsregionalimpairmentsinpediatricpatientswithwolframsyndrome
AT karolinaantosik centralnervoussystempetctimagingrevealsregionalimpairmentsinpediatricpatientswithwolframsyndrome
AT piotrgnys centralnervoussystempetctimagingrevealsregionalimpairmentsinpediatricpatientswithwolframsyndrome
AT dobromilabaranska centralnervoussystempetctimagingrevealsregionalimpairmentsinpediatricpatientswithwolframsyndrome
AT wojciechmlynarski centralnervoussystempetctimagingrevealsregionalimpairmentsinpediatricpatientswithwolframsyndrome
_version_ 1725023658152296448